Shares of Pacific Biosciences of California fell 9.23% to $27.09 at 15:25 EST on Monday, after three successive sessions in a row of losses. NASDAQ Composite is falling 0.33% to $13,916.40, following the last session’s downward trend, This seems, up to now, a somewhat rough trend trading session today.

Pacific Biosciences of California’s last close was $29.85, 98.19% under its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 74.5% for the ongoing quarter and 71.5% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $27.09 at 15:25 EST, way below its 52-week high of $53.69 and way higher than its 52-week low of $2.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $33.94 and higher than its 200-day moving average of $24.72.

More news about Pacific Biosciences of California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here